Recent claims suggest that the United States is leveraging stablecoins to manipulate economic stability and devalue national debt, according to an analysis by a Russian presidential advisor. The discussion highlights the growing influence of cryptocurrency and blockchain technology on global financial systems and the potential geopolitical implications of these digital assets. Accusations of US Strategic [...]Recent claims suggest that the United States is leveraging stablecoins to manipulate economic stability and devalue national debt, according to an analysis by a Russian presidential advisor. The discussion highlights the growing influence of cryptocurrency and blockchain technology on global financial systems and the potential geopolitical implications of these digital assets. Accusations of US Strategic [...]

Putin Adviser Warns US Uses Stablecoins and Gold to Devalue $37T Debt

Putin Adviser Warns Us Uses Stablecoins And Gold To Devalue $37t Debt

Recent claims suggest that the United States is leveraging stablecoins to manipulate economic stability and devalue national debt, according to an analysis by a Russian presidential advisor. The discussion highlights the growing influence of cryptocurrency and blockchain technology on global financial systems and the potential geopolitical implications of these digital assets.

Accusations of US Strategic Use of Stablecoins

The advisor asserts that the U.S. government employs stablecoins—cryptocurrencies pegged to fiat currencies like the US dollar—as tools to control economic outcomes. The argument posits that the widespread adoption of stablecoins in the DeFi ecosystem allows for unprecedented financial maneuvering, including efforts to devalue debt and aid American economic interests. This perspective casts the US as manipulating the relatively decentralized crypto space to serve broader geopolitical aims.

Critics argue that such moves could undermine traditional financial systems and global currency stability, especially amid increasing scrutiny of crypto regulation by governments worldwide. With the rapid growth of cryptocurrency markets, including bitcoin, Ethereum, and various altcoins, the influence of digital assets continues to expand into traditional finance and international policy arenas.

Implications for Global Financial Stability

The use of stablecoins in this context raises concerns about the future of crypto regulation and the integrity of financial markets. As the US explores more sophisticated digital asset strategies, questions arise regarding transparency, accountability, and the potential for destabilizing economic practices. Regulators worldwide are watching closely as the lines between digital currencies and mainstream finance blur, prompting calls for clearer rules to prevent misuse.

Furthermore, the growing integration of blockchain technology and cryptocurrencies into traditional financial systems makes it essential for policymakers to develop comprehensive frameworks. These would aim to balance innovation with risk management, ensuring that the benefits of decentralized finance (DeFi), non-fungible tokens (NFTs), and crypto assets support economic growth without enabling manipulative tactics or abuses by state actors.

Conclusion

The assertion that the US is using stablecoins to influence or devalue debt underscores the ongoing debate about the role of cryptocurrency in geopolitics and global finance. As blockchain technology continues to reshape economic landscapes, international cooperation and robust regulation will be vital to maintaining stability and preventing potential misuse of digital assets. The evolving crypto regulation landscape remains pivotal in balancing innovation with security, ensuring cryptocurrencies contribute positively to the future of finance.

This article was originally published as Putin Adviser Warns US Uses Stablecoins and Gold to Devalue $37T Debt on Crypto Breaking News – your trusted source for crypto news, Bitcoin news, and blockchain updates.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của CEO Bitget Gracy Chen Trở Thành Hiện Thực Và Tầm Nhìn Về Đích Đến 5.400 USD

Thị trường tài chính toàn cầu vừa chứng kiến một khoảnh khắc lịch sử chấn động: Giá Vàng thế giới [...] The post Vàng Cán Mốc Lịch Sử 5.000 USD: Khi Dự Báo Của
Share
Vneconomics2026/02/10 16:26
Why the Bitcoin Boom Is Not Another Tulip Mania

Why the Bitcoin Boom Is Not Another Tulip Mania

Bitcoin is an amazing success story. It was only invented in January of 2009 and was only worth a tiny fraction of a cent for each token. Over just a few years
Share
Medium2026/02/10 15:44
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26